GuaiFENesin 800 mg / dextromethorphan HBr 60 mg 12HR Extended Release Oral Tablet
RxNorm 252091
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 252091 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: guaiFENesin 800 mg / dextromethorphan HBr 60 mg 12HR Extended Release Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCD
Semantic Clinical Drug (SCD):
12 HR dextromethorphan hydrobromide 60 mg / guaifenesin 800 mg Extended Release Oral Tablet
(Atom ID: 12331250)
TMSY
Tall Man Lettering Synonym (TMSY):
12 HR dextromethorphan hydrobromide 60 mg / guaiFENesin 800 mg Extended Release Oral Tablet
(Atom ID: 12382712)
SY
Synonym (SY):
Dextromethorphan HBr 60 mg / guaifenesin 800 mg 12 HR Extended Release Oral Tablet
(Atom ID: 10895607)
TMSY
Tall Man Lettering Synonym (TMSY):
Dextromethorphan HBr 60 mg / guaiFENesin 800 mg 12 HR Extended Release Oral Tablet
(Atom ID: 10896609)
PSN